Jan-Willem Henning

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Idiopathic Pulmonary Fibrosis

Peritoneal Dialysis

Early Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Eliya Farah, Chantelle Carbonell, Devon J Boyne, Darren R Brenner, Jan-Willem Henning, Daniel Moldaver, Simran Shokar, Winson Y Cheung
Treatment Patterns and Health Outcomes among Patients with HER2 IHC0/-Low Metastatic or Recurrent Breast Cancer. Cancers 16 (3) (2024)
Eliya Farah, Chantelle Carbonell, Devon J Boyne, Darren R Brenner, Jan-Willem Henning, Daniel Moldaver, Simran Shokar, Winson Y Cheung
Treatment Patterns and Health Outcomes among Patients with HER2 IHC0/-Low Metastatic or Recurrent Breast Cancer. Cancers 16 (3) (2024)
Jan-Willem Henning, Christine Brezden-Masley, Karen Gelmon, Stephen Chia, Shane Shapera, Micheal C McInnis, Daniel Rayson, Jamil Asselah
Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (9) (2023)
Jan-Willem Henning, Jean-François Boileau, Larissa Peck, Thomas McFarlane
Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (8) (2023)